Profile picture

Doctor Xiaocong Marston

Shanghai (China)
Follow
Logo ESC

Contributor content

Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study
Presentation
Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources